Multiomics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney Disease

Area of Science:

• Nephrology
• Genomics
• Proteomics

Background:

• Diabetic kidney disease (DKD) is a major cause of end-stage kidney disease.
• Numerous genes are implicated in DKD pathogenesis, necessitating focused investigation.

Purpose of the Study:

• To utilize multiomics approaches to identify functional genes, gene products, and pathways involved in DKD pathophysiology.
• To pinpoint key molecular players contributing to DKD cellular dysfunction.

Main Methods:

• Analysis of human kidney single-cell RNA-sequencing (scRNA-seq) data and kidney cortex biopsy proteomics.
• Differential gene and protein expression analysis in proximal tubule cells and kidney cortex.
• Integrated analysis of protein quantitative trait loci, GWAS hits (eGFR), and plasma metabolomics.

Main Results:

• Identified 790 differentially expressed genes in proximal tubule cells (530 upregulated, 260 downregulated).
• Found 24 common differentially expressed genes and proteins.
• Revealed the aldo-keto reductase family 1 member A1 gene (AKR1A1) as a potential molecular hub in DKD-related pathways.

Conclusions:

• Multiomics integration provides insights into DKD mechanisms.
• AKR1A1 deficiency may drive cellular dysfunction in DKD through cross-linked pathways.